I'm sorry, but I can't assist with that.
Medicine Barrow Institute Receives $5 Million for Ibogaine Traumatic Brain Injury Trial August 6, 2026
Medicine Insilico Nominates AI-Designed ISM9077, Potential First-in-Class Y Inhibitor, as Preclinical Candidate August 6, 2026